To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Instylla lands $25.4m Series B
Bedford, Massachusetts-based Instylla Inc, a developer of minimally invasive liquid embolic products designed for use in peripheral vascular embolotherapy, has closed $25.4 million in Series B financing.
